BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16148178)

  • 1. Evaluation of three immunoassays used for detection of anti-rubella virus immunoglobulin M antibodies.
    Dimech W; Panagiotopoulos L; Marler J; Laven N; Leeson S; Dax EM
    Clin Diagn Lab Immunol; 2005 Sep; 12(9):1104-8. PubMed ID: 16148178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System.
    van Helden J; Denoyel G; Karwowska S; Reamer R; Schmalz J; Wright T; Preisel-Simmons B
    Clin Lab; 2004; 50(1-2):63-73. PubMed ID: 15000222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the new ARCHITECT Rubella IgM assay.
    Eichler R; Prostko J; Fischer C; Hausmann M; Christ H
    J Clin Virol; 2007 Jul; 39(3):182-7. PubMed ID: 17543576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European performance evaluations of the ADVIA Centaur infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnostics.
    Dati F; Denoyel G; van Helden J
    J Clin Virol; 2004 Apr; 30 Suppl 1():S6-10. PubMed ID: 15062761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of fully automated assays for the detection of Rubella IgM and IgG antibodies by the Elecsys(®) immunoassay system.
    van Helden J; Grangeot-Keros L; Vauloup-Fellous C; Vleminckx R; Masset F; Revello MG
    J Virol Methods; 2014 Apr; 199():108-15. PubMed ID: 24487099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory.
    Taylor P; Pickard G; Gammie A; Atkins M
    J Clin Virol; 2004 Apr; 30 Suppl 1():S11-5. PubMed ID: 15062762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two commercial immunoassays for the detection of anti-rubella IgM and IgG in pediatric patients.
    Oliveira LC; Okay TS; Kawasato KH; Lima LP
    J Immunoassay Immunochem; 2007; 28(3):297-306. PubMed ID: 17613675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance evaluation of the ADVIA Centaur anti-HBe and HBeAg assays.
    van Helden J; Cornely C; Dati F; Levy HR; Bal T; Seeger M; Wright T; Baker L
    J Clin Virol; 2008 Oct; 43(2):169-75. PubMed ID: 18635392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of rubella virus immunoglobulin G (IgG) and IgM assays with the new Vidia instrument.
    Medici MC; Martinelli M; Albonetti V; Chezzi C; Dettori G
    J Clin Microbiol; 2008 May; 46(5):1847-9. PubMed ID: 18367579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of rubella IgM enzyme immunoassays.
    Tipples GA; Hamkar R; Mohktari-Azad T; Gray M; Ball J; Head C; Ratnam S
    J Clin Virol; 2004 Jul; 30(3):233-8. PubMed ID: 15135741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of a new HIV 1/O/2 assay on the Bayer ADVIA Centaur immunoassay system.
    van Helden J; Denoyel G; Freeman J; Preisel-Simmons B
    Clin Lab; 2004; 50(1-2):83-90. PubMed ID: 15000224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of rubella immunoglobulin M from dried venous blood spots using a commercial enzyme immunoassay.
    Karapanagiotidis T; Riddell M; Kelly H
    Diagn Microbiol Infect Dis; 2005 Oct; 53(2):107-11. PubMed ID: 16168610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays.
    Kwon JA; Yoon SY; Lee CK; Lim CS; Lee KN; Sung HJ; Brennan CA; Devare SG
    J Virol Methods; 2006 Apr; 133(1):20-6. PubMed ID: 16313975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal screening for hepatitis B and antibodies to Toxoplasma gondii and rubella virus: evaluation of two commercial immunoassay systems.
    Diepersloot RJ; Dunnewold-Hoekstra H; Kruit-Den Hollander J; Vlaspolder F
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):785-7. PubMed ID: 11427427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of four enzyme immunoassays for detection of immunoglobulin M antibodies against rubella virus.
    Matter L; Gorgievski-Hrisoho M; Germann D
    J Clin Microbiol; 1994 Sep; 32(9):2134-9. PubMed ID: 7814536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a new hepatitis C assay on the Bayer ADVIA Centaur Immunoassay System.
    Denoyel G; van Helden J; Bauer R; Preisel-Simmons B
    Clin Lab; 2004; 50(1-2):75-82. PubMed ID: 15000223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a new enzyme immunoassay based on recombinant Rubella virus-like particles for detection of immunoglobulin M antibodies to Rubella virus.
    Grangeot-Keros L; Enders G
    J Clin Microbiol; 1997 Feb; 35(2):398-401. PubMed ID: 9003604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital microfluidic platform for the detection of rubella infection and immunity: a proof of concept.
    Ng AH; Lee M; Choi K; Fischer AT; Robinson JM; Wheeler AR
    Clin Chem; 2015 Feb; 61(2):420-9. PubMed ID: 25512641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter.
    Dimech W; Panagiotopoulos L; Francis B; Laven N; Marler J; Dickeson D; Panayotou T; Wilson K; Wootten R; Dax EM
    J Clin Microbiol; 2008 Jun; 46(6):1955-60. PubMed ID: 18434559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-center evaluation of the hepatitis B surface antigen (HBsAg) assay and HbsAg confirmatory assay for the family of Access immunoassay systems.
    Lunel-Fabiani F; Duburcq X; Levayer T; Descamps F; Maniez-Montreuil M; Pivert A; Ducancelle A; Pouzet A; Marant L; Clèment A; Duhamel D; Leirens Y; Margotteau F; Falcou-Briatte R; Heinen C; Bouniort F; Taskar S; Artus A; Woodrum D; Flecheux O
    Clin Lab; 2010; 56(7-8):281-90. PubMed ID: 20857892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.